Navigation Links
New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures
Date:12/9/2008

Studies Presented at American Epilepsy Society Annual Meeting

ATLANTA, Dec. 9 /PRNewswire-FirstCall/ -- UCB today announced findings from new studies of the once-daily antiepileptic drug (AED) Keppra XR(TM) (levetiracetam) extended-release tablets comparing tolerability versus levetiracetam immediate release (IR) and reporting on additional dosing schedules. The data were among five studies that were presented at the 62nd annual meeting of the American Epilepsy Society (AES) in Seattle.

Keppra XR was approved by the U.S. Food and Drug Administration in September 2008 for use as adjunctive treatment for people with partial-onset seizures who are 16 years of age and older.

"In this new meta-analysis, patients taking Keppra XR experienced fewer nervous system side effects than those taking the same dose of twice daily levetiracetam," said James Zackheim, Medical Director, CNS, UCB. "Keppra XR is the only once-daily, extended-release formulation of levetiracetam, and there is no generic alternative available."

Summary of Keppra XR Data Presented at 2008 AES Annual Meeting

Safety Profile of Levetiracetam Extended Release Compared to Immediate Release: An Indirect Comparison Using a Meta-Analytic Approach

Researchers conducted a meta-analysis of Phase III data to determine whether Keppra XR is associated with any tolerability advantages versus the same daily dose of levetiracetam IR. According to the meta-analysis, patients taking Keppra XR once-daily had lower rates of some adverse events versus levetiracetam IR twice-daily.

-- In terms of overall tolerability, 52.8% of Keppra XR patients reported any adverse event, compared with 79% of patients taking levetiracetam IR.

-- While adverse events associated with levetiracetam IR were also observed with Keppra XR, patients treated with Keppra XR once
'/>"/>

SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Keppra XR(TM) Extended-Release Tablets Filed with the FDA
2. UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets
3. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
4. New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting
5. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
6. SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
7. Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer
8. Late-Breaking Data Highlighting Research Advances in Several Blood Disorders to Be Presented At the American Society of Hematology Annual Meeting
9. Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects
10. Opportunities to Highlight Type 1 Diabetes in November
11. Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Research and Markets ( ... "Investigation Report on China,s Insulin Aspart Market, ... Developed by Novo Nordisk, insulin aspart (under the ... for the treatment of diabetes. Compared with human ... analog, starts working fast and reports higher peak ...
(Date:8/28/2015)... , Aug. 28, 2015  IP Shakti, LLC, today announced ... Logo - ... "Our new corporate identity signifies our transformation into a ... predictive analytics platform for patent claim validity." ... of the proprietary AIA Shield™ platform, the Company commenced a ...
(Date:8/28/2015)... PITTSBURGH , Aug. 28, 2015 /PRNewswire/ ... that its shareholders have approved Mylan,s proposed acquisition ... TASE) and the related issuance of Mylan ordinary ... meeting of shareholders held today. The transaction received ... extraordinary general meeting. In addition, the transaction received ...
Breaking Medicine Technology:China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9
... 25, 2011 The Wound and Hyperbaric ... by the Undersea and Hyperbaric Medical Society (UHMS), the ... that few hospitals and facilities have earned, and identifies ... The super oxygenation offered by hyperbaric treatments can ...
... a privately held medical device company focused on developing ... Aspen™ Spinous Process Fixation System (Aspen) was featured in ... Advanced Spine Techniques (IMAST) in Copenhagen, Denmark, July 13th ... Lanx, commented, "These scientific sessions at IMAST add to ...
Cached Medicine Technology:Good Samaritan Hospital's Wound and Hyperbaric Institute Receives Accreditation from Undersea and Hyperbaric Medical Society, Recognizing Advanced Care 2Good Samaritan Hospital's Wound and Hyperbaric Institute Receives Accreditation from Undersea and Hyperbaric Medical Society, Recognizing Advanced Care 3Lanx, Inc. Announces Aspen™ Spinous Process Fixation System Clinical Data at IMAST 2Lanx, Inc. Announces Aspen™ Spinous Process Fixation System Clinical Data at IMAST 3
(Date:8/29/2015)... ... August 29, 2015 , ... ... extend and improve the lives of patients, according to a newly published report. ... to read the full article. , The authors of the new paper ...
(Date:8/29/2015)... (PRWEB) , ... August 29, 2015 , ... ... failure, angina, chronic obstructive pulmonary disease (including emphysema), or asthma, are at higher ... as angina, previous heart attack, heart failure or heart-rhythm problems (arrhythmia or irregular ...
(Date:8/28/2015)... ... August 28, 2015 , ... Joining a growing number ... recently transitioned management companies to partner with Wound Care Advantage (WCA) to utilize ... center. , Transitioning wound care management providers can be a complex undertaking. ...
(Date:8/28/2015)... ... August 28, 2015 , ... With the goal of furthering ... the second year to the Adams County Fairgrounds in Mendon, IL on May 30th, ... money to support music education in the underfunded school districts of Mendon and its ...
(Date:8/28/2015)... , ... August 28, 2015 , ... On May 30th, ... joined as sponsor of the “Music With A Mission” benefit concert in Mendon, IL. ... event was to raise money to support music education programs in the underfunded local ...
Breaking Medicine News(10 mins):Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:Heart Fit Clinic Sounds the Alarm on Forest Fire Smoke and Chronic Heart Disease in Calgary Area 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2
... gaining popularity across the world. However, thousands of people ... stores, experts said yesterday.// , ,It is estimated ... conditions ranging from eczema to the menopause. But the ... ,Health chiefs say 67 in Britain are being ...
... its determination to gear up to meet the avian flu ... keep a close watch on bird flu cases and also ... M A Hakeem said "Though we have no cases of ... measures and the committee to be formed will include representatives ...
... his verdict over the right of teenage under-16s girl to ... which has been brought by Ms Axon as one of ... family planning association told the court that parents are mostly ... does not match the views of their children’s. Law has ...
... attempt to fulfill the shortage of Dentists in Britain, ... training for an examination that could get them jobs ... the Karnataka-based Manipal Bapuji Postgraduate Medical (& Dental) Faculty ... vacancies of dentists in Britain. ,"India is ...
... has been established between age-related macular degeneration and the ... been confirmed by the identification of a bacterium //called ... individuals. It is also notable that the microorganism is ... ,Researchers found C. pneumoniae in the diseased eye tissue ...
... Diabetes Day is observed on November 14 in order to create awareness ... in common - a problem with insulin, and has reached epidemic proportions. ... As a part of the World Diabetes Day, a walk ... at 7.30 am from IMA hall, Panagal road and end at the ...
Cached Medicine News:Health News:Avian Influenza: Government to set up expert committee 2Health News:Doctors take part in walk: a step towards creating diabetes awareness , , 2
All purpose, low profile punches with a large square bite....
... With the OPMI Vario/NC33 System, Carl ... invasive spine market. , ,The success ... solely attributable to its extremely compact and ... by the first graphical touchscreen to be ...
... uniquely combines solutions for basic requirements ... intra-operative diagnostics, integration of the entire ... surgical microscope into the hospital's information ... for OR staff.,OPMI Pentero is the ...
Osteoprep instruments provide an array of bone shaping devices especially suited for notchplasties....
Medicine Products: